Sujets

Sur cette page, les lecteurs peuvent obtenir une liste de documents classifiés par thèmes. Cliquez sur le nom du thème pour voir affichées les sous-thèmes ou pour revenir aux thèmes principaux. Cliquez sur l'icône d'un sous-thème pour obtenir la liste des documents qui s'y rapportent. Les publications sont disponibles en HTML, PDF

, DOC

ou XLS

format. Veuillez cliquer sur l'icône correspondante pour accéder à la publication. La publication est disponible uniquement en format PDF lorsque l'icône PDF est située sur la page de couverture de la publication. Si l'icône PDF est située près du titre de la publication, les formats HTML et PDF sont disponibles.


		Page d'accueil de l'OMS

		OMS - Systèmes et services de santé

		OMS - Médicaments

		Sites OMS

		Page d'accueil - Publications et documents sur les médicaments

		Rechercher

		Titres A-Z

		Sujets

		Mots-clés

		Séries et Périodiques

		Éditeurs

		Auteurs A-Z

		Régions

		Pays

		Index

		Sous-collections

		Public sub-collections

Publications de l'OMS - Publications non-OMS - Tous

Anglais - Français - Espagnol - Russe

Étendre le menu Sous-collections.

248 documents en 3 pages

« Précédent | Tous | Détails

Afficher Tous | Cacher Tous

Medicine Information and Evidence for Policy

Medicines Policy

Ouvrir ce document et afficher son contenu

Titre:	The Indian Pharmaceutical Sector: Issues and Options for Health Sector Reform
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Chellaraj, Gnanaraj; Govindaraj, Ramesh
An:	2002 Pages: 80
Éditeurs:	The World Bank (WB)
Pays:	Inde

Titre:	Innovation and Access to Medicines for Neglected Populations: Could a Treaty Address a Broken Pharmaceutical R&D System?
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing
Auteur:	Bermudez, Jorge A. Z.; Moon, Suerie; 't Hoen, Ellen
An:	2012 Pages: 5
Régions:	Global

Titre:	Intellectual Property and Access to Medicines. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 3)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Musungu, Sisule F.
An:	2012 Pages: 21
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Intellectual Property in the Context of the WTO TRIPS Agreement: Challenges for Public Health [Spanish]
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Bermudez, Jorge A. Z.; Oliveira, Maria Auxiliadora
An:	2004 Pages: 170
Éditeurs:	WHO Collaborating Centre for Pharmaceutical Policies (Rio de Janeiro, Brazil) Oswaldo Cruz Foundation
Régions:	Global
Pays:	Brésil

Titre:	International Policy Overview: Antibiotic Resistance
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Antimicrobial Drug Resistance
Auteur:	Gerards, Marieke
An:	2011 Pages: 23
Régions:	Global; Europe (EURO)
Pays:	Pays-Bas

Titre:	Intervening in Global Markets to Improve Access to HIV/AIDS Treatment: An Analysis of International Policies and the Dynamics of Global Antiretroviral Medicines Markets
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Supply Management
Auteur:	Bärnighausen, Till; Diedrichsen, Ellen; Hochstadt, Jenny; Kyle, Margaret; Moon, Suerie; Soucy, Lyne; Waning, Brenda
An:	2010 Pages: 19
Régions:	Global

Titre:	Inventory Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 23)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
Auteur:	Dias, Vimal
An:	2012 Pages: 24
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Investigating Medicine Use. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 28)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Rational Use
Auteur:	Matowe, Lloyd
An:	2012 Pages: 23
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Is Access to Essential Medicines As Part Of The Fulfilment of the Right to Health Enforceable Through the Courts?
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Casanovas, Jaume Vidal; Hogerzeil, Hans V; Rahmani-Ocora, Ladan; Samson, Melanie
An:	2006 Pages: 7
Régions:	Global

Titre:	Kenya National Drug Policy, July 1994
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	1994 Pages: 18
Éditeurs:	Kenya Ministry of Health
Pays:	Kenya

Titre:	Kenya National Pharmaceutical Policy, 2008
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2008 Pages: 60
Éditeurs:	Kenya - Ministry for Medical Services
Pays:	Kenya

Titre:	Kit System Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 26)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
Auteur:	den Besten, Henk
An:	2012 Pages: 16
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Laboratory Services and Medical Supplies. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 47)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
Auteur:	Mundy, Catherine
An:	2012 Pages: 19
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Lao National Drug Policy Programme
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Andersson, Göran; Helling-Borda, Margaretha
An:	2000 Pages: 102
Éditeurs:	Swedish International Development Cooperation Agency, SIDA
Pays:	République démocratique populaire lao

Titre:	Local Production of Medical Technologies and Its Effect on Access in Low and Middle Income Countries: A Systematic Review of the Literature - Southern Med Review Vol 4 Issue 2 Dec 2011
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Supply Management
Auteur:	Kaplan, Warren Allan; Ritz, Lindsay Sarah; Vitello, Marie
An:	2011 Pages: 11
Éditeurs:	Southern Med Review
Régions:	Global

Titre:	Local Production of Pharmaceuticals and Related Technology Transfer in Developing Countries: A Series of Case Studies by the UNCTAD Secretariat
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Supply Management
An:	2011 Pages: 320
Éditeurs:	United Nations (UN) United Nations Conference on Trade and Development (UNCTAD )
Documents similaires:	Increasing Access to Diagnostics Through Technology Transfer and Local Production Local Production for Access to Medical Products: Developing a Framework to Improve Public Health Local Production and Access to Medicines in Low- and Middle-income Countries: A Literature Review and Critical Analysis Trends in Local Production of Medicines and Related Technology Transfer Pharmaceutical Production and Related Technology Transfer: Landscape Report
Régions:	Global

Titre:	Local Production of Pharmaceuticals: Industrial Policy and Access to Medicines. An Overview of Key Concepts, Issues and Opportunities for Future Research
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
Auteur:	Kaplan, Warren; Laing, Richard
An:	2005 Pages: 54
Éditeurs:	The World Bank (WB)
Régions:	Global

Titre:	Making National Drug Policies a Development Priority. A Strategy Paper and Six Country Stories
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Andrew, Marit; Bidwai, Praful; Chowdhury, Zafrullah; Gasman, Nadine; Jøldal, Bjørn; Murray, Mary; Tomson, Göran; Weerasuriya, Krisantha
An:	1995 Pages: 260
Éditeurs:	The Dag Hammarskjöld Foundation
Documents similaires:	A Search for Balance: Pharmaceuticals in Sri Lanka. Pioneering Steps in a Receptive Environment and Subsequent Accommodations Norway’s National Drug Policy: Its Evolution and Lessons for the Future Bangladesh: A Tough Battle for a National Drug Policy Australian National Drug Policies: Facilitating or Fragmenting Health? One Step Forward, Many Steps Back: Dismemberment of India’s National Drug Policy Drifting Through Time: Pharmaceutical Policies in Mexico
Régions:	Global

Titre:	Malaysian Statistics on Medicines 2007 (Published 2010)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2010 Pages: 194
Éditeurs:	Malaysia Ministry of Health
Pays:	Malaisie

Titre:	Managing Distribution. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 22)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
Auteur:	Clark, Malcolm
An:	2012 Pages: 21
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Managing for Rational Medicine Use. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 27)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Rational Use
Auteur:	Chalker, John
An:	2012 Pages: 16
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Managing Medicine Selection. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 16)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Selection
Auteur:	Olson, Christopher
An:	2012 Pages: 16
Éditeurs:	Management Sciences for Health (MSH) Swiss Tropical Institute
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Managing Pharmaceutical Programs. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 37)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Programme Coordination > Human Resources for Pharmaceutical Sector Medicine Programme Coordination > Programme Coordination
Auteur:	Vriesendorp, Sylvia
An:	2012 Pages: 21
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Managing Procurement. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 18)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
Auteur:	Barraclough, Andrew; Clark, Malcolm
An:	2012 Pages: 27
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Managing the Tender Process. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 21)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management Quality and Safety: Medicines > Regulatory Support Prequalification of Medicines > WHO-UNICEF-UN Project
Auteur:	Clark, Malcolm; Heltzer, Ned; Rankin, James
An:	2012 Pages: 28
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Maximising the Benefits from Generic Competition
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing
Auteur:	Seeley, Elizabeth
An:	2008 Pages: 12
Éditeurs:	European Observatory on Health Systems and Policies
Documents similaires:	Generic Policies: Rhetoric vs. Reality Generic Policies and the Generics Paradox
Liens associés:	http://www.euro.who.int/en/who-we-are/partners/observatory/euro-observer
Régions:	Global; Europe (EURO)

Titre:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing Medicine Access and Rational Use > Rational Use Medicine Access and Rational Use > Selection Medicine Access and Rational Use > Supply Management Traditional Medicine > Traditional, Complementary and Herbal Medicine Quality and Safety: Medicines > Quality Assurance Quality and Safety: Medicines > Regulatory Support
An:	2012 Pages: 1088
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	Toward Sustainable Access to Medicines. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 1) Historical and Institutional Perspectives. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 2) Intellectual Property and Access to Medicines. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 3) National Medicine Policy. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 4) Traditional and Complementary Medicine Policy. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 5) Pharmaceutical Legislation and Regulation. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 6) Pharmaceutical Production Policy. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 7) Pharmaceutical Pricing Policy. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 9) Economics for Pharmaceutical Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 10) Pharmaceutical Financing Strategies. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 11) Pharmaceutical Benefits in Insurance Program. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 12) Revolving Drug Funds and User Fees. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 13) Global and Donor Financing. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 14) Pharmaceutical Donations. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 15) Managing Medicine Selection. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 16) Treatment Guidelines and Formulary Manuals. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 17) Pharmaceutical Supply Strategies. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 8) Managing Procurement. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 18) Quality Assurance for Pharmaceuticals. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 19) Quantifying Pharmaceutical Requirements. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 20) Managing the Tender Process. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 21) Managing Distribution. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 22) Inventory Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 23) Importation and Port Clearing. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 24) Transport Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 25) Kit System Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 26) Managing for Rational Medicine Use. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 27) Investigating Medicine Use. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 28) Promoting Rational Prescribing. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 29) Ensuring Good Dispensing Practices. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 30) Community-Based Participation and Initiatives. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 31) Drug Seller Initiatives. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 32) Encouraging Appropriate Medicine Use by Consumers. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 33) Medicine and Therapeutics Information. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 34) Pharmacovigilance. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 35) Pharmaceutical Supply Systems Assessment. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 36) Managing Pharmaceutical Programs. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 37) Planning for Pharmaceutical Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 38) Contracting for Pharmaceuticals and Services. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 39) Analyzing and Controlling Pharmaceutical Expenditures. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 40) Financial Planning and Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 41) Planning and Building Storage Facilities. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 42) Security Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 43) Medical Stores Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 44) Hospital Pharmacy Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 45) Pharmaceutical Management for Health Facilities. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 46) Laboratory Services and Medical Supplies. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 47) Monitoring and Evaluation. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 48) Pharmaceutical Management Information Systems. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 49) Computers in Pharmaceutical Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 50) Human Resources Management and Capacity Development. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 51) Designing and Implementing Training Programs. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 52) MDS-3: Managing Access to Medicines and Health Technologies. Front Matter, including Contributors, Reviewers, Contents, and How to Use MDS-3 MDS-3: Managing Access to Medicines and Health Technologies. Index
Liens associés:	http://www.msh.org/resource-center/managing-drug-supply.cfm
Régions:	Global

Titre:	MDS-3: Managing Access to Medicines and Health Technologies. Front Matter, including Contributors, Reviewers, Contents, and How to Use MDS-3
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
Auteur:	Quick, Jonathan D
An:	2012 Pages: 9
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	The Mectizan (Ivermectin) Donation Program for Riverblindness as a Paradigm for Pharmaceutical Industry Donation Programs
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
Auteur:	Berk, David W; Coyne, Philip E
An:	2002 Pages: 32
Éditeurs:	The World Bank (WB)
Régions:	Global

Titre:	Medical Stores Management. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 44)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Supply Management
Auteur:	Dias, Vimal
An:	2012 Pages: 24
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Medicine and Therapeutics Information. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 34)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Rational Use Medicine Access and Rational Use > Selection
Auteur:	Johnson, Keith
An:	2012 Pages: 17
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Medicines and Insurance Coverage (MedIC) Initiative Course on Medicines Policy Analysis in Health Insurance Systems. Accra, Ghana, 16 to 25 November 2008
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing
Auteur:	Wagner, Anita K
An:	2009 Pages: 64
Éditeurs:	WHO Collaborating Center in Pharmaceutical Policy at the Department of Ambulatory Care and Prevention of Harvard Medical School and Harvard Pilgrim Health Care World Health Organization - Regional Office for Africa (WHO/AFRO) Ghana, Ministry of Health Noguchi Memorial Institute for Medical Research
Pays:	Ghana

Titre:	Medicines Policy 2020. Towards Efficient, Safe, Rational and Cost-effective Use of Medicines - Finland
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2011 Pages: 45
Éditeurs:	Finland - Ministry of Social Affairs and Health
Liens associés:	http://www.stm.fi/en/publications/publication/-/_julkaisu/1551199
Pays:	Finlande

Titre:	Millennium Development Goal 8. Strengthening the Global Partnership for Development in a Time of Crisis. MDG Gap Task Force Report 2009. United Nations, New York [Arabic] [Chinese] [French] [Russian] [Spanish]
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing
An:	2009 Pages: 92
Éditeurs:	United Nations (UN)
Documents similaires:	Millennium Development Goal 8. The Global Partnership for Development at a Critical Juncture. MDG Gap Task Force Report 2010. United Nations, New York
Régions:	Global

Titre:	Millennium Development Goal 8. The Global Partnership for Development at a Critical Juncture. MDG Gap Task Force Report 2010. United Nations, New York [Arabic] [Chinese] [French] [Russian] [Spanish]
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
An:	2010 Pages: 102
Éditeurs:	United Nations (UN)
Documents similaires:	Millennium Development Goal 8. Strengthening the Global Partnership for Development in a Time of Crisis. MDG Gap Task Force Report 2009. United Nations, New York
Régions:	Global

Titre:	Millennium Development Goal 8. The Global Partnership for Development: Making Rhetoric a Reality. MDG Gap Task Force Report 2012. United Nations, New York [Arabic] [Chinese] [French] [Russian] [Spanish]
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
An:	2012 Pages: 107
Éditeurs:	United Nations (UN)
Liens associés:	http://www.un.org/en/development/desa/policy/mdg_gap/index.shtml
Régions:	Global

Titre:	Millennium Development Goal 8. The Global Partnership for Development: Time to Deliver. MDG Gap Task Force Report 2011. United Nations, New York [Arabic] [Chinese] [French] [Russian] [Spanish]
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Financing Medicine Access and Rational Use > Pricing
An:	2011 Pages: 100
Éditeurs:	United Nations (UN)
Régions:	Global

Titre:	UN Millennium Project. 2005. Prescription for Healthy Development: Increasing Access to Medicines. Report of the Task Force on HIV/AIDS, Malaria, TB, and Access to Essential Medicines, Working Group on Access to Essential Medicines.
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2005 Pages: 188
Éditeurs:	United Nations (UN)
Régions:	Global

Titre:	Monitoring and Evaluation. (MDS-3: Managing Access to Medicines and Health Technologies, Chapter 48)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Information and Evidence for Policy > Monitoring and Evaluation
Auteur:	Miralles, Maria
An:	2012 Pages: 20
Éditeurs:	Management Sciences for Health (MSH)
Documents similaires:	MDS-3: Managing Access to Medicines and Health Technologies (Third Edition)
Liens associés:	http://www.msh.org/resource-center/mds-3-digital-edition.cfm
Régions:	Global

Titre:	Myths, Questions, Facts About Generic Drugs in the EU
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Access and Rational Use > Pricing Quality and Safety: Medicines > Quality Assurance
Auteur:	Baumgärtel, Christoph
An:	2012 Pages: 5
Régions:	Europe (EURO)

Titre:	National Antimalarial Treatment Policy, February 2005 - Nigeria
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2005 Pages: 31
Éditeurs:	Nigeria - Federal Ministry of Health, National Malaria and Vector Control Division (Abuja-Nigeria)
Pays:	Nigéria

Titre:	National Drug Policy (2005 – 2009)- Republic of The Sudan [Arabic]
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2005 Pages: 21
Éditeurs:	Sudan Federal Ministry of Health
Pays:	Soudan

Titre:	National Drug Policy - Pakistan, 2003
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2003 Pages: 18
Éditeurs:	Pakistan Ministry of Health
Pays:	Pakistan

Titre:	National Drug Policy -1995 (And Draft National Medicines Policy – 2007) - Nepal
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2007 Pages: 13
Éditeurs:	Nepal Ministry of Health
Pays:	Népal

Titre:	National Drug Policy 2005 - Bangladesh
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2005 Pages: 12
Éditeurs:	Bangladesh, Ministry of Health and Family Welfare, Government of the People's Republic of Bangladesh
Pays:	Bangladesh

Titre:	National Drug Policy for Namibia
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy Medicine Programme Coordination > Programme Coordination
An:	1998 Pages: 50
Éditeurs:	Namibia Ministry of Health and Social Services
Pays:	Namibie

Titre:	National Drug Policy for South Africa, 1996
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	1996 Pages: 31
Éditeurs:	South Africa/Pretoria National Department of Health
Pays:	Afrique du Sud

Titre:	National Drug Policy of the Transitional Government of Ethiopia, November 1993 (English / Amharic)
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	1993 Pages: 28
Éditeurs:	Transitional Government of Ethiopia
Pays:	Ethiopie

Titre:	National Drug Policy of Trinidad and Tobago, 1998
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	1998 Pages: 38
Éditeurs:	Trinidad and Tobago - Ministry of Health
Pays:	Trinité-et-Tobago

Titre:	National Drug Policy, 2007 - 2012 - New Zealand, March 2007
Sujets:	Medicine Information and Evidence for Policy > Medicines Policy
An:	2007 Pages: 46
Éditeurs:	New Zealand - Ministry of Health, Ministerial Committee on Drug Policy
Pays:	Nouvelle-Zélande


	« Précédent 1 2 3

Dernière mise à jour: le 3 mai 2013